Showing 161-170 of 2293 results for "".
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn-0707-dementia-pdf/31141/In the realm of dementia care, accurate CPT (Current Procedural Terminology) coding is crucial for appropriate reimbursement and reflecting the complexity of patient management. David S. Geldmacher, MD, addresses the challenges neurologists face when utilizing CPT codes for dementia evaluations in h
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0806PainManagement-pdf/31287/Complex Regional Pain Syndrome (CRPS) presents significant challenges in long-term pain management, as demonstrated in Charles Argoff, MD’s article in Practical Neurology. CRPS is categorized into Type I (formerly Reflex Sympathetic Dystrophy) and Type II (formerly Causalgia). While both types share
- Examining the Health of Medical Malpractice Coveragehttps://practicalneurology.com/columns/practice-management/examining-the-health-of-medical-malpractice-coverage/31035/Medical malpractice litigation remains a significant concern for neurologists, ranking high among professional anxieties alongside breaches of medical ethics. According to Marc Nuwer, MD, PhD of UCLA, a substantial number of physicians face lawsuits during their careers, often driven not by actual m
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0407-painmngmt-pdf/31193/Chronic Pain Management: Addressing Potential Bias in Clinical AssessmentsChronic pain remains a significant challenge in neurology, often complicated by the subjective nature of pain assessment. In the article "Are You Guilty of Bias When Encountering Unexplained Pain?" by Charles Argoff, MD, publi
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN1106painMngmt-pdf/31257/Using Opioids for Chronic Pain Therapy: Balancing Efficacy and RisksChronic pain management remains a significant challenge in neurology, with opioids serving as a potent, yet controversial, option. In his comprehensive article, Charles Argoff, MD, Director of the Cohn Pain Management Center at Nort
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0405PainMngnt-pdf/31468/Chronic pain management represents a significant yet underutilized area within the neurology specialty. At the recent American Academy of Neurology (AAN) annual meeting, Charles Argoff, MD, emphasized the necessity for neurologists to adopt a more active role in treating chronic pain conditions. Des
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn1008_10-pdf/30986/Choosing Between Short- and Long-Acting Opioids in Chronic Pain ManagementIn the realm of chronic pain management, selecting the appropriate opioid analgesic—whether short-acting or long-acting—remains a nuanced decision due to limited comparative data. Charles Argoff, MD, in his recent article for
Potential Uses of ATX(N) Classification of Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/potential-uses-of-atxn-classification-of-alzheimer-disease/31792/The ATX(N) classification system has potential uses in clinical practice and therapy development for Alzheimer disease.Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Multiple Sclerosis and COVID-19
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-and-covid-19/31725/Understanding the immune system, drug proposed mechanisms of action, and considerations for care during COVID-19.